Xencor Inc. Stock
Xencor Inc. Stock
Xencor Inc. gained 1.850% today.
We see a rather positive sentiment for Xencor Inc. with 15 Buy predictions and 2 Sell predictions.
As a result the target price of 22 € shows a very positive potential of 100.0% compared to the current price of 11.0 € for Xencor Inc..
Pros and Cons of Xencor Inc. in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
S********** s********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Xencor Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Xencor Inc. | 1.850% | 3.774% | 6.796% | 22.905% | -13.386% | -56.349% | -69.739% |
| United Therapeutics | -1.950% | 4.439% | 11.379% | 69.931% | 14.533% | 143.725% | 198.415% |
| Ionis Pharmaceuticals Inc. | 0.830% | 0.621% | -7.530% | 144.957% | -4.591% | 96.634% | 69.428% |
| Novocure Ltd | -2.330% | -10.373% | -20.883% | -44.694% | -19.347% | -83.519% | -91.924% |
Comments
Xencor (XNCR) had its price target raised by Barclays PLC from $26.00 to $27.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for XNCR provided by MarketBeat
Xencor (NASDAQ:XNCR) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.
Show more
Ratings data for XNCR provided by MarketBeat
Xencor (NASDAQ:XNCR) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $26.00 price target on the stock.
Show more
Ratings data for XNCR provided by MarketBeat